SLS BIO Co., Ltd (KOSDAQ:246250)
South Korea flag South Korea · Delayed Price · Currency is KRW
1,969.00
+85.00 (4.51%)
At close: Jun 9, 2025

SLS BIO Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2015
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '15
Net Income
-5,428-4,904335.631,4342,826204.47
Depreciation & Amortization
1,2561,2831,3361,2781,303616.03
Loss (Gain) From Sale of Assets
25.13-0.1400.01-40.3-4
Loss (Gain) on Equity Investments
---39.06236.35-
Stock-Based Compensation
-0.293.7511.7732.79-
Provision & Write-off of Bad Debts
4477.64133.8734.8721.57
Other Operating Activities
387.11791.6467.69-139.84-278.15324.4
Change in Accounts Receivable
-45.991,166118.111,076-202.97-564.81
Change in Inventory
1.351.358.6474.96-99.5-
Change in Accounts Payable
-20.82-243.79-472.39339.5982.8314.99
Change in Other Net Operating Assets
111.6-293.02-149.13-812.36138.74112.13
Operating Cash Flow
-3,701-2,1951,7263,4364,034724.79
Operating Cash Flow Growth
---49.76%-14.83%456.58%-17.73%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2015
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '15
Capital Expenditures
-1,108-1,514-1,456-1,274-719.23-627.13
Sale of Property, Plant & Equipment
76.250.2--203.644
Sale (Purchase) of Intangibles
-24.73-17.53-43.37-134.44-15.39-348.6
Investment in Securities
6,0243,490997.32-6,509-1,012-1,499
Other Investing Activities
24-15-0-0.78-0.52-71.52
Investing Cash Flow
4,9911,944-502.34-7,918-1,543-2,538

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2015
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '15
Long-Term Debt Issued
-----200
Total Debt Issued
500----200
Short-Term Debt Repaid
-----1,770-312
Long-Term Debt Repaid
--614.99-589.58-579.91-574.71-1,124
Total Debt Repaid
-631.16-614.99-589.58-579.91-2,345-1,436
Net Debt Issued (Repaid)
-131.16-614.99-589.58-579.91-2,345-1,236
Issuance of Common Stock
---5,660-3,626
Repurchase of Common Stock
---899.88---
Dividends Paid
---383.71---
Other Financing Activities
---27.8-302.2--187.77
Financing Cash Flow
-131.16-614.99-1,9014,777-2,3452,203

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2015
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '15
Miscellaneous Cash Flow Adjustments
-0-00--0-
Net Cash Flow
1,159-865.94-677.09294.84146.05389.11

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2015
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '15
Free Cash Flow
-4,809-3,709269.922,1623,31597.66
Free Cash Flow Growth
---87.51%-34.79%3294.14%-88.45%
Free Cash Flow Margin
-166.44%-93.09%3.22%23.96%30.83%1.57%
Free Cash Flow Per Share
-319.96-246.4517.69153.75483.2619.58
Levered Free Cash Flow
-2,239-1,893-3.661,255--559.57
Unlevered Free Cash Flow
-2,200-1,85248.791,318--349.34

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2015
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '15
Cash Interest Paid
30.5---23.37175.57
Cash Income Tax Paid
--16.4236.536.471.093.06
Change in Working Capital
46.14630.3-494.76678.68-80.9-437.68